Shares of Johnson & Johnson JNJ, -1.55% shed 1.55% to $172.32 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -0.34% falling 0.34% to 4,520.03 and Dow Jones Industrial Average DJIA, -0.76% falling 0.76% to 35,100.00. The stock’s fall snapped a three-day winning streak. Johnson & Johnson closed $7.60 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. RHHVF, -0.95% fell 0.95% to $393.74, Merck & Co. Inc. MRK, -1.66% fell 1.66% to $75.98, and Pfizer Inc. PFE, -0.19% fell 0.19% to $46.75. Trading volume (6.6 M) eclipsed its 50-day average volume of 5.6 M.